The University of Naples Federico II is a public university in Naples, Italy. Founded in 1224, it is the oldest public non-sectarian university in the world, and is now organized into 26 departments.

During the past decade, Università degli Studi di Napoli Federico II conducted 50 clinical trials. In the 10-year time frame, 50 clinical trials started and 20 clinical trials were completed, i.e. on average, 40% percent of trials that started reached the finish line to date. In the past 5 years, 23 clinical trials started and 9 clinical trials were completed. i.e. 39.1% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Università degli Studi di Napoli Federico II" #1 sponsor was "Federico II University" with 19 trials, followed by "Boehringer Ingelheim" with 8 trials sponsored, "Ipsen" with 5 trials sponsored, "Consorzio Oncotech" with 4 trials sponsored and "Shire" with 4 trials sponsored. Other sponsors include 55 different institutions and companies that sponsored additional 56 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Università degli Studi di Napoli Federico II" #1 collaborator was "Federico II University" with 6 trials as a collaborator, "Clinical Research Technology S.r.l." with 2 trials as a collaborator, "Eli Lilly and Company" with 2 trials as a collaborator, "Agenzia Italiana del Farmaco" with 1 trials as a collaborator and "Agnelli Hospital, Italy" with 1 trials as a collaborator. Other collaborators include 35 different institutions and companies that were collaborators in the rest 45 trials.

According to Clinical.Site data, the most researched conditions in "Università degli Studi di Napoli Federico II" are "Acromegaly" (5 trials), "Heart Failure" (3 trials), "Metastatic Breast Cancer" (3 trials), "Chronic Kidney Disease" (2 trials) and "Colon Cancer" (2 trials). Many other conditions were trialed in "Università degli Studi di Napoli Federico II" in a lesser frequency.

Most popular intervention types in "Università degli Studi di Napoli Federico II" are "Drug" (59 trials), "Other" (13 trials), "Procedure" (7 trials), "Behavioral" (4 trials) and "Dietary Supplement" (4 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (10 trials), "placebo" (4 trials), "Bortezomib" (2 trials), "Daratumumab" (2 trials) and "Dexamethasone" (2 trials). Other intervention names were less common.

The vast majority of trials in "Università degli Studi di Napoli Federico II" are 86 trials for "All" genders, 12 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Università degli Studi di Napoli Federico II". undefined are not yet recruiting, 13 are recruiting, 5 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 61 completed trials in Università degli Studi di Napoli Federico II, undefined suspended trials, and 6 terminated clinical trials to date.

Out of the total trials that were conducted in Università degli Studi di Napoli Federico II, 2 "Phase 1" clinical trials were conducted, 18 "Phase 2" clinical trials and 30 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 11 trials, and there were also 17 trials that are defined as “Not Applicable".

Università degli Studi di Napoli Federico II has several departments that took part in Clinical trials: "Università degli Studi Federico II; Clinica di Oncologia Medica" - 24 trials, "Federico II University Medical School" - 18 trials, "A. O. U. Federico II; Dip Neuroscienze, Scienze Riproduttive ed Odontostomatologiche" - 12 trials, "Department of Traslational Medical Science - University of Naples Federico II" - 8 trials, "federico II university, department of nephrology" - 7 trials, "Department of Clinical Medicine and Surgery" - 5 trials, "A.O. Universitaria Federico II Di Napoli; Oncologia Ed Endocrinologia Clinica" - 4 trials, "Ambulatorio Ipertensione e Unità Coronarica Federico II University" - 4 trials, "Department of Molecular and Clinical Endocrinology and Oncology, University Federico II of Naples" - 4 trials, "Nuovo Policlinico, Ii Facolta; Divisione Di Ematologia" - 2 trials, "Department of Agricultural Sciences" - 2 trials, "Department of Advanced Biomedical Sciences, University of Naples "Federico II"" - 2 trials, "Prof Marco Picardi - Hematology - AOU FEDERICO II" - 2 trials, "Department of Neuroscience, Federico II University Naples" - 2 trials, "Federico II University - Department of Internal Medicine" - 2 trials, "Department of Food Science" - 2 trials, "AOU Seconda Università degli Studi; Dip. Assistenziale Integrato Medicina Int-II Clinica Neurologica" - 2 trials